scispace - formally typeset
A

Arun Malhotra

Researcher at All India Institute of Medical Sciences

Publications -  205
Citations -  3836

Arun Malhotra is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: PET-CT & Positron emission tomography. The author has an hindex of 32, co-authored 205 publications receiving 3429 citations. Previous affiliations of Arun Malhotra include AIIMS, New Delhi.

Papers
More filters
Journal ArticleDOI

The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan.

TL;DR: 18F-fluoride PET/CT has the potential to replace the 99mTc-MDP bone scan for the detection of bone metastases and is the most reliable investigation.
Journal ArticleDOI

Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis

TL;DR: In osteosarcoma, chemotherapy response can be predicted and evaluated by conventional and diffusion-weighted MRI early in the disease course and it correlates well with necrosis, and newly derived parameter diffusion per unit volume appears to be a sensitive substitute for response evaluation in osteosARcoma.
Journal Article

Technetium Tc-99m Ethyl Cysteinate Dimer Brain Single-Photon Emission CT in Mild Traumatic Brain Injury: A Prospective Study

TL;DR: Tc99m-ECD SPECT can be used as a complementary technique to CT in initial evaluation of patients with MTBI and is particularly useful in patients having PCS, LOC, or PTA with normal CT scan.
Journal ArticleDOI

18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.

TL;DR: 18F-FDOPA PET/CT is highly sensitive and specific for detection of recurrence in glioma patients and is especially advantageous in patients with low-grade gliomas.
Journal ArticleDOI

The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer

TL;DR: In conclusion, 18F-FDG PET/CT can differentiate responders from non-responders with high accuracy after two cycles of NACT in patients with LABC.